Stock NHI NATIONAL HEALTH INVESTORS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials National Health Investors, Inc.

Equities

NHI

US63633D1046

Specialized REITs

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
62.89 USD +0.45% Intraday chart for National Health Investors, Inc. +2.23% +12.61%
Apr. 18 Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting CI
Mar. 18 Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,582 3,094 2,635 2,266 2,424 2,731 - -
Enterprise Value (EV) 1 5,017 4,550 3,841 3,394 2,424 4,025 4,056 4,131
P/E ratio 22.2 x 16.7 x 23.6 x 35.3 x 17.8 x 22.1 x 20.9 x 20.7 x
Yield 5.15% 6.38% 6.62% 6.89% - 5.75% 5.83% 5.96%
Capitalization / Revenue 11.3 x 9.3 x 8.82 x 8.14 x 7.58 x 8.53 x 7.76 x 6.45 x
EV / Revenue 15.8 x 13.7 x 12.9 x 12.2 x 7.58 x 12.6 x 11.5 x 9.75 x
EV / EBITDA 16.9 x 14.8 x 14.4 x 13.5 x - 16 x 15.4 x 16 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 2.32 x - 1.75 x 1.77 x - 2.08 x 2.02 x 1.97 x
Nbr of stocks (in thousands) 43,961 44,729 45,851 43,389 43,410 43,425 - -
Reference price 2 81.48 69.17 57.47 52.22 55.85 62.89 62.89 62.89
Announcement Date 2/19/20 2/22/21 2/22/22 2/21/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 318.1 332.8 298.7 278.2 319.8 320.2 352 423.5
EBITDA 1 296.8 308.1 266.6 251.8 - 251.3 262.9 257.7
EBIT 1 220 224.9 185.8 180.9 - 183.6 198.6 209.9
Operating Margin 69.17% 67.58% 62.22% 65.03% - 57.33% 56.43% 49.56%
Earnings before Tax (EBT) 1 160.4 185.3 112 65.5 134.4 120.5 131.7 135.2
Net income 1 160.5 185.1 111.8 66.4 135.6 123.3 133.8 136.3
Net margin 50.45% 55.62% 37.43% 23.87% 42.4% 38.5% 38.02% 32.18%
EPS 2 3.670 4.140 2.440 1.480 3.130 2.840 3.006 3.031
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 4.200 4.410 3.802 3.600 - 3.618 3.666 3.748
Announcement Date 2/19/20 2/22/21 2/22/22 2/21/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 73.83 69.67 71.33 59.9 76.3 70.67 82.39 77.88 80.11 79.46 76.86 78.82 81.22 83.3 85.09
EBITDA 1 66.41 61.3 61.48 69.44 61.58 60.06 62.19 61.21 63.44 - 62.08 63.46 64.19 64.52 64.65
EBIT 1 46.38 42 43.2 30.26 49.51 42.75 44.57 43.48 43.18 - 42.85 45.19 47.24 48.29 47.85
Operating Margin 62.81% 60.29% 60.57% 50.52% 64.89% 60.5% 54.1% 55.83% 53.9% - 55.75% 57.34% 58.16% 57.98% 56.23%
Earnings before Tax (EBT) 1 30.85 6.505 8.246 21.47 34.23 1.56 34.18 39.45 29.03 31.72 27.84 29.64 31.33 31.68 31.51
Net income 1 30.81 6.475 8.399 21.67 34.47 1.863 34.48 39.76 29.33 32.03 29.23 30.72 31.56 31.78 32.1
Net margin 41.73% 9.29% 11.78% 36.18% 45.18% 2.64% 41.86% 51.06% 36.61% 40.3% 38.03% 38.97% 38.86% 38.15% 37.73%
EPS 2 0.6700 0.1300 0.1800 0.4700 0.7800 0.0500 0.7900 0.9200 0.6800 0.7400 0.6800 0.7133 0.7233 0.7233 0.7232
Dividend per Share 2 0.9000 0.9000 0.9000 0.9000 0.9000 0.9000 0.9000 0.9000 0.9000 - 0.9000 0.9056 0.9056 0.9056 0.9056
Announcement Date 11/8/21 2/22/22 5/9/22 8/8/22 11/8/22 2/21/23 5/9/23 8/8/23 11/7/23 2/20/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,435 1,456 1,205 1,128 - 1,294 1,325 1,400
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.835 x 4.726 x 4.521 x 4.481 x - 5.149 x 5.04 x 5.432 x
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 11.1% - - - - 9.19% 9.48% 9.62%
ROA (Net income/ Total Assets) 5.54% - - - - 4.67% 4.79% 4.87%
Assets 1 2,896 - - - - 2,642 2,794 2,799
Book Value Per Share 2 35.10 - 32.90 29.50 - 30.20 31.10 32.00
Cash Flow per Share 2 - - 4.610 4.140 - 4.400 4.610 4.780
Capex 1 - 117 - - - 2.6 2.6 2.6
Capex / Sales - 35.07% - - - 0.81% 0.74% 0.61%
Announcement Date 2/19/20 2/22/21 2/22/22 2/21/23 2/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for National Health Investors, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
62.89 USD
Average target price
62.83 USD
Spread / Average Target
-0.09%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

1st Jan change Capi.
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+12.61% 2.73B
WELLTOWER INC. Stock Welltower Inc.
+4.62% 55.76B
VENTAS, INC. Stock Ventas, Inc.
-11.72% 17.72B
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-5.05% 13.23B
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+1.40% 7.68B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-16.54% 5.39B
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+8.62% 3.28B
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
-2.31% 3.23B
AEDIFICA SA Stock Aedifica SA
-5.42% 3.06B
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
-8.15% 2.73B
Healthcare REITs
  1. Stock Market
  2. Equities
  3. NHI Stock
  4. Financials National Health Investors, Inc.